Dan Roden
-
Six Basic Sciences faculty among this year’s ‘highly cited’ researchers
They are among 6,868 scientists worldwide whose papers rank in the top 1% by citations for their fields of research and publication year in the Web of Science Core Collection over the past 11 years. Read MoreNov. 20, 2025
-
Eleven Vanderbilt scientists among world’s “highly cited” researchers
The Highly Cited Researchers list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges,” said Emmanuel Thiveaud, PhD, senior vice president for Research and Analytics at Clarivate. Read MoreNov. 19, 2024
-
Minor early changes in lungs can signal changes in progressive lung disease
The research focused on the very early stages of FPF, a serious progressive lung disease where for unknown reasons scar tissue builds up in the lungs over time. Read MoreOct. 3, 2024
-
Roden honored for his leadership in precision medicine
Dan Roden, MD, Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center, will receive the PMWC 2023 Pioneer Award Jan. 27 during this year’s Precision Medicine World Conference. Approximately 2,500 people from more than 30 countries are registered for the three-day meeting, to be held in Santa Clara,… Read MoreJan. 12, 2023
-
Roden leads effort to map heart disease-causing genetic variations
One in 100 people have genetic variations that can cause potentially life-threatening heart conditions, including high cholesterol (lipid disorders), heart muscle disease (cardiomyopathies), and abnormal heart rhythms (arrhythmias). Yet the functional impact of most of these cardiovascular genetic variants — whether they disrupt normal function or are harmless — is… Read MoreSep. 15, 2022
-
BioVU celebrates 15 years supporting personalized medicine
In 2003, Dan Roden, MD, then director of the Division of Clinical Pharmacology at Vanderbilt University Medical Center, imagined a large-scale biobank integrated with electronic health records to help doctors “personalize” medical care for their patients. That vision became BioVU, today one of the world’s largest biobanks, with… Read MoreJun. 9, 2022
-
Researchers find clue to drug-induced arrhythmias
Researchers at Vanderbilt University Medical Center have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms. Their findings, reported recently in the journal Circulation, add significantly to understanding what causes abnormal heart rhythms, or arrhythmias, and… Read MoreFeb. 25, 2022